Laurel Wealth Advisors (California)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.57M Buy
5,995
+341
+6% +$91.4K 0.16% 147
2022
Q3
$1.27M Buy
5,654
+19
+0.3% +$4.61K 0.14% 165
2022
Q2
$1.37M Sell
5,635
-691
-11% -$169K 0.14% 161
2022
Q1
$1.53M Sell
6,326
-732
-10% -$168K 0.13% 174
2021
Q4
$1.59M Buy
7,058
+1,924
+37% +$406K 0.12% 168
2021
Q3
$1.09M Sell
5,134
-403
-7% -$92.8K 0.2% 119
2021
Q2
$1.35M Sell
5,537
-224
-4% -$55.1K 0.17% 131
2021
Q1
$1.43M Sell
5,761
-50
-0.9% -$11.9K 0.22% 107
2020
Q4
$1.34M Sell
5,811
-216
-4% -$49.8K 0.2% 122
2020
Q3
$1.53M Sell
6,027
-51
-0.8% -$12.6K 0.25% 94
2020
Q2
$1.43M Buy
6,078
+78
+1% +$17.8K 0.26% 96
2020
Q1
$1.22M Sell
6,000
-152
-2% -$33.2K 0.28% 100
2019
Q4
$1.48M Sell
6,152
-487
-7% -$107K 0.25% 110
2019
Q3
$1.28M Buy
6,639
+684
+11% +$131K 0.22% 119
2019
Q2
$1.1M Buy
5,955
+48
+0.8% +$8.6K 0.24% 113
2019
Q1
$1.12M Buy
5,907
+595
+11% +$114K 0.28% 98
2018
Q4
$1.03M Sell
5,312
-644
-11% -$126K 0.3% 90
2018
Q3
$1.23M Buy
5,956
+15
+0.3% +$2.96K 0.3% 91
2018
Q2
$1.1M Buy
5,941
+349
+6% +$61.7K 0.29% 92
2018
Q1
$953K Sell
5,592
-55
-1% -$10.1K 0.3% 88
2017
Q4
$982K Buy
5,647
+892
+19% +$158K 0.28% 92
2017
Q3
$886K Buy
4,755
+331
+7% +$58.6K 0.3% 89
2017
Q2
$762K Buy
4,424
+52
+1% +$8.46K 0.27% 99
2017
Q1
$717K Sell
4,372
-350
-7% -$58.2K 0.28% 98
2016
Q4
$690K Sell
4,722
-7
-0.1% -$1.05K 0.31% 92
2016
Q3
$789K Sell
4,729
-221
-4% -$37.4K 0.37% 76
2016
Q2
$753K Buy
4,950
+322
+7% +$50.1K 0.36% 76
2016
Q1
$694K Sell
4,628
-315
-6% -$46.8K 0.35% 78
2015
Q4
$802K Buy
+4,943
New +$777K 0.41% 70

Other funds holding AMGN

Laurel Wealth Advisors (California)'s AMGN Position: Q4 2022 in Review

Laurel Wealth Advisors (California) increased its Amgen (AMGN) stake by 6% in Q4 2022, buying an estimated $91.4K and bringing the position to 5,995 shares worth $1.57M. The position accounts for 0.16% of the portfolio, ranked #147.

Laurel Wealth Advisors (California) first reported a position in AMGN in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.59M in Q4 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Laurel Wealth Advisors (California) held 5,995 shares of Amgen worth $1.57M as of Q4 2022.
  • Laurel Wealth Advisors (California) bought 341 Amgen shares in Q4 2022, an estimated $91.4K.
  • Amgen made up 0.16% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #147 holding.
  • Laurel Wealth Advisors (California) first reported a position in Amgen in Q4 2015 and has held it in 29 quarters since.
  • Laurel Wealth Advisors (California)'s Amgen position peaked at $1.59M in Q4 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.